MC
ABBV icon

Mathes Company’s AbbVie ABBV Stock Holding History

Mathes Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Hold
1,000
– – 0.08% 119
2025
Q4 		$228K Hold
1,000
– – 0.08% 118
2025
Q3 		$232K Buy
+1,000
New +$204K 0.08% 119
2024
Q2 		– Sell
-1,311
Closed -$239K – 129
2024
Q1 		$239K Hold
1,311
– – 0.09% 124
2023
Q4 		$203K Buy
+1,311
New +$191K 0.08% 127
2022
Q4 		$226K Buy
+1,400
New +$215K 0.11% 116
2022
Q3 		– Sell
-1,400
Closed -$214K – 126
2022
Q2 		$214K Hold
1,400
– – 0.1% 119
2022
Q1 		$227K Buy
+1,400
New +$203K 0.09% 124
2015
Q3 		– Sell
-3,495
Closed -$235K – 127
2015
Q2 		$235K Buy
+3,495
New +$228K 0.13% 137

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mathes Company's ABBV Position: Q1 2026 in Review

Mathes Company held its AbbVie (ABBV) position steady in Q1 2026 at 1,000 shares worth $217K. The position accounts for 0.08% of the portfolio, ranked #119.

Mathes Company first reported a position in ABBV in Q2 2015 and has held it in 9 quarters since. The position peaked at $239K in Q1 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Mathes Company held 1,000 shares of AbbVie worth $217K as of Q1 2026.
  • Mathes Company left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.08% of Mathes Company's portfolio in Q1 2026, its #119 holding.
  • Mathes Company first reported a position in AbbVie in Q2 2015 and has held it in 9 quarters since.
  • Mathes Company's AbbVie position peaked at $239K in Q1 2024.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Mathes Company's 13F filing for Q1 2026, filed 8 May 2026.